Impax Laboratories, Inc.
(NASDAQ : IPXL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
2.59%209.952.9%$545.59m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
-0.52%17.102.1%$419.59m
MYLMylan N.V.
0.64%31.503.1%$194.64m
ZTSZoetis, Inc. Class A
-0.88%63.601.9%$130.09m
IPXLImpax Laboratories, Inc.
-0.65%22.8510.9%$34.16m
ABEOAbeona Therapeutics, Inc.
-3.85%14.389.3%$21.71m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
-2.89%36.572.1%$13.86m
TXMDTherapeuticsMD, Inc.
-1.14%6.1029.5%$10.34m
TAROTaro Pharmaceutical Industries Ltd.
1.42%110.656.1%$9.06m
PETXAratana Therapeutics, Inc.
-2.42%6.069.9%$1.38m
KINKindred Biosciences, Inc.
0.34%7.430.4%$0.72m
LFVNLifeVantage Corporation
-0.47%4.273.3%$0.43m
JAGXJaguar Animal Health, Inc.
14.97%0.478.3%$0.18m
BSPMBioStar Pharmaceuticals, Inc.
-0.74%1.3411.7%$0.04m
CPHIChina Pharma Holdings, Inc.
-0.45%0.200.1%$0.03m

Company Profile

Impax Laboratories, Inc. operates as a technology based specialty pharmaceutical company, which engages in the development, manufacture, and marketing of controlled-release and niche generics. It operates through the Impax Generics and Impax Specialty Pharma segments. The Impax Generics segment concentrates on the development manufacture, sale and distribution of generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are usually marketed under their established nonproprietary drug names rather than by a brand name. The Impax Specialty Pharma segment engages in the development of proprietary brand pharmaceutical products. The company was founded on December 14, 1999 and is headquartered in Hayward, CA.